ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0592

Gender Modifies the Effect of Rheumatoid Arthritis on All-Cause Mortality

Srikanta Banerjee1 and Stephanie Falls2, 1Walden University, Leola, 2PA Department of Health, Leola

Meeting: ACR Convergence 2021

Keywords: gender, Mortality, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Epidemiology & Public Health Poster II: Inflammatory Arthritis – RA, SpA, & Gout (0560–0593)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic and systemic autoimmune disease which predominantly affects joints with varying severity. While RA has been found to be more prevalent in women, there is conflicting information about gender-specific mortality rate as it relates to RA. In this study, we explored the relationship between RA and all-cause mortality and if gender modifies this effect.

Methods: The study was conducted on participants aged 20 years or older in the United States living. We assessed RA status by using the arthritis screening in the NHANES survey for the years 1999 to 2010 with mortality follow-up through December 31, 2015. Prospective analysis was performed using complex samples Cox Regression with adjustment for known confounders to determine the relationship of RA and mortality, especially as it pertains to gender.

Results: Prevalence of RA in this population (N=27,371) was 1.9% among males and 2.8% among females. The mean follow-up was 11.1 years. For all-cause mortality, the overall unadjusted hazard ratio (HR) of rheumatoid arthritis to no rheumatoid arthritis was 2.89 (95% confidence interval [CI], 2.48-3.37, p < 0.001). Adjusted HR was elevated, 1.34 (CI 1.04-1.73, p < 0.05), among female participants with RA but closer to 1.0 (1.02 CI 0.83-1.25, p > 0.05) among male participants with RA, after controlling for medical (obesity, diabetes, CKD, and CVD) and demographic risk factors (age, education, and food insecurity).

Conclusion: RA was found to cause three times higher mortality rate than the general population, which is higher than previous estimates. The findings also show that RA disproportionately affects females and also leads to worse outcome than in males. Risk scoring and social policy, when addressing RA, should address gender disparities related to outcomes.

Table 1. Multivariable Cox Hazard Model for Rheumatoid Arthritis and all-cause mortality after controlling for demographic and medical risk factors stratified by gender.


Disclosures: S. Banerjee, None; S. Falls, None.

To cite this abstract in AMA style:

Banerjee S, Falls S. Gender Modifies the Effect of Rheumatoid Arthritis on All-Cause Mortality [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/gender-modifies-the-effect-of-rheumatoid-arthritis-on-all-cause-mortality/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gender-modifies-the-effect-of-rheumatoid-arthritis-on-all-cause-mortality/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology